Robin Shane Readnour Sells 10,019 Shares of Anthem (NASDAQ:ANTX) Stock

Posted by Brenda Bartman on Sep 10th, 2026

Anthem, Inc. (NASDAQ:ANTX – Get Free Report) Director Robin Shane Readnour sold 10,019 shares of the company’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $6.02, for a total transaction of $60,314.38. Following the completion of the sale, the director owned 557,990 shares in the company, valued at approximately $3,359,099.80. This trade represents a 1.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Robin Shane Readnour also recently made the following trade(s):

On Thursday, September 3rd, Robin Shane Readnour sold 6,100 shares of Anthem stock. The stock was sold at an average price of $6.07, for a total transaction of $37,027.00.
On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The stock was sold at an average price of $6.01, for a total value of $212,766.02.

Anthem Stock Down 4.2%

Shares of Anthem stock opened at $5.73 on Thursday. The firm has a market cap of $216.25 million, a P/E ratio of -5.36 and a beta of -0.99. Anthem, Inc. has a fifty-two week low of $1.00 and a fifty-two week high of $7.19. The business has a 50-day moving average price of $5.35 and a 200 day moving average price of $4.44.

Anthem (NASDAQ:ANTX – Get Free Report) last released its earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Institutional Trading of Anthem

Several hedge funds have recently made changes to their positions in ANTX. Spruce Street Capital LP acquired a new position in Anthem during the 1st quarter valued at approximately $5,576,000. OMERS ADMINISTRATION Corp bought a new stake in Anthem in the first quarter valued at $54,000. Commodore Capital LP bought a new stake in Anthem in the first quarter valued at $7,981,000. ADAR1 Capital Management LLC bought a new stake in Anthem in the first quarter valued at $47,000. Finally, Ally Bridge Group NY LLC acquired a new position in shares of Anthem during the first quarter valued at $1,800,000. Institutional investors own 90.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Leerink Partners upgraded Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price objective on the stock in a research note on Thursday, May 14th. Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Guggenheim assumed coverage on shares of Anthem in a report on Monday, July 20th. They set a “buy” rating and a $9.00 target price on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Anthem in a research report on Monday, July 6th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Anthem has an average rating of “Hold” and an average target price of $9.00.

Read Our Latest Stock Analysis on ANTX

Anthem Company Profile

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.